Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Fennec Pharmaceuticals (FENC) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Fennec Pharmaceuticals (FENC) over the last 15 years, with Q3 2025 value amounting to 0.13%.

  • Fennec Pharmaceuticals' Return on Capital Employed fell 1600.0% to 0.13% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.13%, marking a year-over-year decrease of 1600.0%. This contributed to the annual value of 0.09% for FY2024, which is 7500.0% up from last year.
  • As of Q3 2025, Fennec Pharmaceuticals' Return on Capital Employed stood at 0.13%, which was down 1600.0% from 0.26% recorded in Q2 2025.
  • Fennec Pharmaceuticals' 5-year Return on Capital Employed high stood at 0.16% for Q1 2024, and its period low was 1.63% during Q2 2023.
  • In the last 5 years, Fennec Pharmaceuticals' Return on Capital Employed had a median value of 0.69% in 2021 and averaged 0.64%.
  • In the last 5 years, Fennec Pharmaceuticals' Return on Capital Employed tumbled by -5500bps in 2023 and then skyrocketed by 17300bps in 2024.
  • Fennec Pharmaceuticals' Return on Capital Employed (Quarter) stood at 0.65% in 2021, then tumbled by -66bps to 1.08% in 2022, then grew by 26bps to 0.8% in 2023, then skyrocketed by 107bps to 0.06% in 2024, then crashed by -319bps to 0.13% in 2025.
  • Its last three reported values are 0.13% in Q3 2025, 0.26% for Q2 2025, and 0.32% during Q1 2025.